Author Question: Explain gout in leukemia. What will be an ideal response?[br][br][b][color=#A83E49]Question ... (Read 156 times)

bobypop

  • Hero Member
  • *****
  • Posts: 539
Explain gout in leukemia.
 
  What will be an ideal response?

Question 2

Compare and contrast: primary versus secondary gout.
 
  What will be an ideal response?



dpost18

  • Sr. Member
  • ****
  • Posts: 345
Answer to Question 1

Leukemia can cause an increase in the level of uric acid in the blood secondary to an increased number of white blood cells and following treatment with drugs that destroy the leukemic cells. There is an increased breakdown of nucleoprotein yielding a large amount of uric acid and the inadequate renal excretion of uric acid from the excessive breakdown of nucleoprotein.

Answer to Question 2

Primary gout results from the metabolic disorder of purine metabolism with crystallization of uric acid within the joint that incites an intense inflammatory reaction.
Secondary gout is any condition that increases the level of uric acid in the blood with hyperuricemia resulting from decreased renal excretion of uric acid or increased nucleoprotein breakdown.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

As the western states of America were settled, pioneers often had to drink rancid water from ponds and other sources. This often resulted in chronic diarrhea, causing many cases of dehydration and death that could have been avoided if clean water had been available.

Did you know?

The people with the highest levels of LDL are Mexican American males and non-Hispanic black females.

Did you know?

Malaria mortality rates are falling. Increased malaria prevention and control measures have greatly improved these rates. Since 2000, malaria mortality rates have fallen globally by 60% among all age groups, and by 65% among children under age 5.

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

For a complete list of videos, visit our video library